{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:50:08Z","timestamp":1761310208818},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.lungcan.2004.10.003","type":"journal-article","created":{"date-parts":[[2004,12,12]],"date-time":"2004-12-12T00:47:20Z","timestamp":1102812440000},"page":"211-216","source":"Crossref","is-referenced-by-count":29,"title":["Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions"],"prefix":"10.1016","volume":"48","author":[{"given":"Monica","family":"Falleni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Roncalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Nosotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Palleschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Santambrogio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Coggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvano","family":"Bosari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2004.10.003_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00063198-199907000-00015","article-title":"Pleural mesothelioma","volume":"5","author":"Astoul","year":"1999","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.lungcan.2004.10.003_bib2","first-page":"3080","article-title":"Gene expression profiling of malignant mesothelioma","volume":"9","author":"Singhal","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2004.10.003_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/BF00685817","article-title":"Chemotherapy and cytokine sensitivity of malignant mesothelioma","volume":"28","author":"Bowman","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.lungcan.2004.10.003_bib4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.1996.14.3.1007","article-title":"Chemotherapy in malignant pleural mesothelioma. A review","volume":"14","author":"Ong","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2004.10.003_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine post-operative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.lungcan.2004.10.003_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ijc.11209","article-title":"Inductions of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment","volume":"106","author":"Hopkins-Donaldson","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2004.10.003_bib7","first-page":"687","article-title":"Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides","volume":"1","author":"Xia","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.lungcan.2004.10.003_bib8","first-page":"5315","article-title":"Resistance of pleural mesothelioma cell lines to apoptosis: relations to expression of Bcl-2 and Bax","volume":"275","author":"Narasimhan","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lungcan.2004.10.003_bib9","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1038\/sj.onc.1202569","article-title":"The inhibitors of apoptosis (IAPs) and their mergin role in cancer","volume":"17","author":"LaCasse","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2004.10.003_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/excr.1999.4455","article-title":"Escaping cell death: survival proteins in cancer","volume":"248","author":"J\u00e4\u00e4ttel\u00e4","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.lungcan.2004.10.003_bib11","first-page":"2683","article-title":"Therapeutic targeting of Survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis","volume":"9","author":"Blanc-Brude","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2004.10.003_bib12","first-page":"2610","article-title":"p53 and Kirsten-ras mutations in human mesothelioma cell lines","volume":"52","author":"Metcalf","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2004.10.003_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/ajrcmb.16.1.8998073","article-title":"Absence of p53 mutations in malignant mesotheliomas","volume":"16","author":"Mor","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.lungcan.2004.10.003_bib14","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0002-9440(10)64779-7","article-title":"Mechanisms of apoptosis","volume":"157","author":"Reed","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lungcan.2004.10.003_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0009-8981(02)00297-8","article-title":"Apoptosis: biochemical aspects and clinical implication","volume":"326","author":"Kiechle","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.lungcan.2004.10.003_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrc968","article-title":"Validating Survivin as a cancer therapeutic target","volume":"3","author":"Altieri","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.lungcan.2004.10.003_bib17","first-page":"3508","article-title":"Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma","volume":"5","author":"Soini","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2004.10.003_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates cell apoptosis","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2004.10.003_bib19","doi-asserted-by":"crossref","first-page":"7834","DOI":"10.1073\/pnas.92.17.7834","article-title":"Multiple Bcl-2 family members demonstrate selective dimerization with bax","volume":"92","author":"Sedlak","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lungcan.2004.10.003_bib20","first-page":"1941","article-title":"Apoptosis-related factors p53 Bcl-2 and Bax in neuroendocrine lung tumors","volume":"149","author":"Brambilla","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lungcan.2004.10.003_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1097-0215(19960422)69:2<100::AID-IJC5>3.0.CO;2-4","article-title":"Bcl-2\/Bax mRNA expression as a prognostic factor in low grade urinary bladder cancer","volume":"69","author":"Gazzaniga","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2004.10.003_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1097-0215(19960422)69:2<114::AID-IJC8>3.0.CO;2-3","article-title":"Bcl-2 Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression","volume":"69","author":"Aguilar-Santelises","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2004.10.003_bib23","first-page":"1834","article-title":"Hypersensitivity of testicular tumors to etoposide-induced apoptosis is associated with functional p53 and high bax\/bcl-2 ratio","volume":"56","author":"Chresta","year":"1996","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.lungcan.2004.10.003_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF01069743","article-title":"Immunoreactivity for bcl-2 protein in malignant mesotelioma and non neoplastic mesothelium","volume":"424","author":"Segers","year":"1994","journal-title":"Virchows Arch"},{"key":"10.1016\/j.lungcan.2004.10.003_bib25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1165\/ajrcmb.25.5.4539","article-title":"Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma","volume":"5","author":"Cao","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.lungcan.2004.10.003_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1096-9896(199704)181:4<362::AID-PATH764>3.0.CO;2-Y","article-title":"Bcl-2 expression in pleural and extrapleural solitary fibrous tumours","volume":"181","author":"Chilosi","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/j.lungcan.2004.10.003_bib27","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/path.1388","article-title":"Survivin gene expression in early-stage non-small cell lung cancer","volume":"200","author":"Falleni","year":"2003","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.lungcan.2004.10.003_bib28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.LAB.0000017165.26718.60","article-title":"Prediction of survival in stage I lung carcinoma patients by telomerase funtion evaluation","volume":"82","author":"Marchetti","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.lungcan.2004.10.003_bib29","first-page":"5071","article-title":"Inhibition of apoptosis by Survivin predicts shorter survival rates in colorectal cancer","volume":"58","author":"Kawasaki","year":"1998","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.lungcan.2004.10.003_bib30","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E","article-title":"Expression of Survivin correlates with apoptosis, proliferation and angiogenesis during human colorectal tumorigenesis","volume":"91","author":"Kawasaki","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2004.10.003_bib31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/carcin\/23.6.1017","article-title":"Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma","volume":"23","author":"Gordon","year":"2002","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.lungcan.2004.10.003_bib32","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1067\/mtc.2002.121684","article-title":"Antisense therapy with oligonucleotides targeting the bcl-xl gene product","volume":"123","author":"Smithe","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"10.1016\/j.lungcan.2004.10.003_bib33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1172\/JCI14123","article-title":"The Survivin saga goes in vivo","volume":"108","author":"Reed","year":"2001","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.lungcan.2004.10.003_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/hupa.2001.21897","article-title":"Expression of survivin in normal, hyperplastic and neoplastic colonic mucosa","volume":"32","author":"Gianani","year":"2001","journal-title":"Hum Pathol"},{"issue":"79","key":"10.1016\/j.lungcan.2004.10.003_bib35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1172\/JCI13345","article-title":"Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53","volume":"108","author":"Grossman","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lungcan.2004.10.003_bib36","first-page":"8664","article-title":"Evidence that APC regulates Survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer","volume":"62","author":"Zhang","year":"2001","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.lungcan.2004.10.003_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00022744-200106000-00007","article-title":"Expression of Survivin, YB-1, and KI-67 in sporadic adenomas and displasia-associated lesions or masses in ulcerative colitis","volume":"9","author":"Fogt","year":"2001","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1016\/j.lungcan.2004.10.003_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0006-291X(02)02128-9","article-title":"Expression of Survivin during liver regeneration","volume":"297","author":"Deguchi","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lungcan.2004.10.003_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00019606-200203000-00007","article-title":"Expression of Survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma","volume":"11","author":"Ikeguchi","year":"2002","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.lungcan.2004.10.003_bib40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/gut.46.5.645","article-title":"Expression of the antiapoptosis gene, Survivin, predicts death from recurrent colorectal carcinoma","volume":"46","author":"Sarela","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.lungcan.2004.10.003_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3835(02)00190-8","article-title":"Survivin expression correlates with clinical stage, histological grade, invasive behaviour and survival rate in endometrial carcinoma","volume":"184","author":"Takai","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lungcan.2004.10.003_bib42","first-page":"805","article-title":"Expression of Survivin in CIN and invasive squamous cell carcinoma of uterine cervix","volume":"22","author":"Kim","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lungcan.2004.10.003_bib43","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1309\/6V09-38K3-JQ40-UR50","article-title":"Immunohistochemical localisation of Survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma","volume":"117","author":"Frost","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.lungcan.2004.10.003_bib44","first-page":"1121","article-title":"Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment","volume":"9","author":"Ikeguchi","year":"2002","journal-title":"Oncol Rep"},{"issue":"11","key":"10.1016\/j.lungcan.2004.10.003_bib45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1349-7006.2000.tb00906.x","article-title":"Survivin as a radioresistance factor in pancreatic cancer","volume":"91","author":"Asanuma","year":"2000","journal-title":"Jpn J Cancer Res"},{"issue":"9","key":"10.1016\/j.lungcan.2004.10.003_bib46","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1349-7006.2002.tb02483.x","article-title":"Role for survivin in radioresistance of pancreatic cancer cells","volume":"93","author":"Asanuma","year":"2002","journal-title":"Jpn J Cancer Res"},{"issue":"8","key":"10.1016\/j.lungcan.2004.10.003_bib47","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.cgt.7700332","article-title":"Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma","volume":"8","author":"Mohiuddin","year":"2001","journal-title":"Cancer Gene Ther"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500204005288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500204005288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T21:53:29Z","timestamp":1548971609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500204005288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0169500204005288"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2004.10.003","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}